Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 120,000 shares at $51.76 ($6.2M) on 2016-08-18, disclosed to the SEC on 2016-08-22.
Open-market sale of $6.2M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.38 | 6,867 | $353K | 5.7% |
| 2 | $51.76 | 10,822 | $560K | 9.1% |
| 3 | $51.40 | 19,694 | $1.0M | 16.4% |
| 4 | $51.58 | 82,617 | $4.3M | 68.9% |
| Total | $51.56 avg | 120,000 | $6.2M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |